投资者： 为保护中小股东利益，公司是否有计划进一步规范与美丰集团的业务边界？未来是否会推出 诸如资产整合、业务划分等彻底解决品牌混同与潜在同业竞争的具体措施？ 董秘： 投资者您好！谢谢您对公司的关注和建议！ 投资者： 美丰集团经营尿素产品是否会与公司形成客户资源争夺或价格竞争？公司在原材料采购、产 品定价等环节是否存在因关联方竞争导致的利益受损风险？ 截至2026年1月9日收盘，四川美丰(000731)报收于6.71元，上涨0.45%，换手率1.2%，成交量6.6万手， 成交额4432.58万元。 董秘最新回复 董秘： 投资者您好！公司拥有独立、完整的采购、生产、销售体系和面向市场的独立运营能力。公司 关联交易定价遵循市场公允原则，审议决策程序依法合规，不存在损害公司和股东利益的情形，不存在 关联方通过交易干预公司独立运营的情形。谢谢！ 投资者： 针对名称与品牌带来的市场混同效应，公司是否制定了明确的品牌区分策略（如产品标识、 目标客群、销售渠道划分等）？目前该策略的落地效果如何量化评估？ 董秘： 投资者您好！1.公司高度重视品牌资产的清晰与独特性，并将其视为核心无形资产。为防范市场 混同、建立鲜明品牌认知， ...

Financial Performance - The total operating revenue for the first half of 2025 was CNY 889,562,105.55, an increase from CNY 851,310,393.35 in the same period of 2024, reflecting a growth of approximately 4.5% [4] - The total operating costs rose to CNY 854,042,747.91 from CNY 807,609,281.18, indicating an increase of about 5.7% [4] - The net profit for the first half of 2025 was CNY 25,309,202.01, down from CNY 33,409,091.02 in the previous year, representing a decline of approximately 24.2% [4] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,923,975,305.64, a decrease from CNY 1,957,448,719.76 at the beginning of the period [2][3] - Current assets totaled CNY 505,164,172.16, down from CNY 519,008,826.63, showing a reduction of about 2.7% [2] - Total liabilities decreased to CNY 964,112,629.89 from CNY 1,023,791,469.87, a decline of approximately 5.8% [2] Cash Flow - The net cash flow from operating activities was CNY 38,078,904.35, down from CNY 62,337,775.10 in the first half of 2024, indicating a decrease of about 39% [5] - Cash flow from investing activities showed a net outflow of CNY 24,787,217.62, compared to a net outflow of CNY 26,217,996.20 in the previous year [6] - Cash flow from financing activities resulted in a net outflow of CNY 29,908,209.81, down from CNY 67,853,665.79 in the same period of 2024 [6] Equity - Total equity increased to CNY 959,862,675.75 from CNY 933,657,249.89, reflecting a growth of approximately 2.8% [2][3] - The company's retained earnings showed a slight improvement, with an unallocated profit of CNY -142,591,173.39 compared to CNY -167,298,554.14 in the previous year [2][3]